Page last updated: 2024-11-07

prednisone and Basal Ganglia Diseases

prednisone has been researched along with Basal Ganglia Diseases in 6 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smith, D1
Bloch, S1
Al-Rashid, RA1
Caviness, JN1
Knox, CA1
Ravid, S1
Topper, L1
Eviatar, L1
Sinniah, D1
Lin, HP1
Nordstrom, DM1
West, SG1
Andersen, PA1

Other Studies

6 other studies available for prednisone and Basal Ganglia Diseases

ArticleYear
Basal ganglia calcification on CT scanning in children with acute lymphocytic leukemia.
    Neuroradiology, 1980, Volume: 20, Issue:2

    Topics: Basal Ganglia Diseases; Calcinosis; Child; Child, Preschool; Drug Therapy, Combination; Humans; Leuk

1980
Hemidystonia occurring in a patient with sarcoidosis.
    Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:3

    Topics: Adult; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysto

1996
Acute necrotizing encephalopathy presenting as a basal ganglia syndrome.
    Journal of child neurology, 2001, Volume: 16, Issue:6

    Topics: Basal Ganglia; Basal Ganglia Diseases; Biopsy, Needle; Brain; Child; Dose-Response Relationship, Dru

2001
Extrapyramidal tract syndrome following intensive MOPP therapy for stage IV-B Hodgkin's disease in childhood.
    Cancer, 1979, Volume: 43, Issue:5

    Topics: Antineoplastic Agents; Basal Ganglia Diseases; Child; Drug Therapy, Combination; Hodgkin Disease; Hu

1979
Basal ganglia calcifications in central nervous system lupus erythematosus.
    Arthritis and rheumatism, 1985, Volume: 28, Issue:12

    Topics: Adult; Basal Ganglia Diseases; Calcinosis; Electroencephalography; Female; Humans; Lupus Erythematos

1985
Drug-induced extrapyramidal symptoms. A cooperative study.
    JAMA, 1973, May-07, Volume: 224, Issue:6

    Topics: Antidepressive Agents; Antipsychotic Agents; Basal Ganglia Diseases; Butyrophenones; Chlorpromazine;

1973